Clinics in Dermatology
Volume 26, Issue 3 , Pages 265-273 , May 2008

Skin manifestations of inflammatory bowel disease

References 

  1. Loftus EV, Sandborn WJ. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31:1–20
  2. Friedman S, Blumberg R. In: Inflammatory bowel disease in Harrison's principles of internal medicine. 16th ed.. McGraw Hill; 2005;p. 1777–1789[Chapter 276]
  3. Hanauer SB. Update on the etiology, pathogenesis and diagnosis of ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2004;1:26–31
  4. Garcia L, Rodriguez A, Ruigomez A, Panes J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology. 2006;130:1588–1594
  5. Charles N, Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2001;96:1116–1122
  6. Ozdil S, et al. Ulcerative colitis: analyses of 116 cases (do extraintestinal manifestations effect the time to catch remission?). Hepatogastroenterology. 2004;51:768–770
  7. Areias E, Garcia e Silva L. Cutaneous manifestations of ulcerative colitis. Med Cutan Ibero Lat Am. 1987;15:185–197
  8. Wojas-Pelc A, Wielowieyska-Szybinska D, Setkowicz M, Szybinski P, Bogdaszewska-Czabanowska J. Ulcerative colitis concomitant with pyoderma gangrenosum and erythema nodosum—presentation of two cases. Przegl Lek. 2001;58:945–949
  9. Tavarela Veloso F. Review article: skin complications associated with inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20(Suppl 4):50–53[Review]
  10. Evaluation of oral administration of folic and folinic acid to prevent folate deficiency in patients with inflammatory bowel disease treated with salicylazosulfapyridine. Int J Clin Pharmacol Res. 1988;8:143–148
  11. Jarrett P, Duffill M, Oakley A, Smith A. Pellagra, azathioprine and inflammatory bowel disease. Clin Exp Dermatol. 1997;22:44–45
  12. Oliva MM, Lake AM. Nutritional considerations and management of the child with inflammatory bowel disease. Nutrition. 1996;12:151–158[Review]
  13. Boh EE, al-Smadi RM. Cutaneous manifestations of gastrointestinal diseases. Dermatol Clin. 2002;20:533–546[Review]
  14. Yates VM, Watkinson G, Kelman A. Further evidence for an association between psoriasis, Crohn's disease and ulcerative colitis. Br J Dermatol. 1982;106:323–330
  15. Cusano F, Errico G. Lichen planus and ulcerative colitis. Arch Dermatol. 1984;120:994–995
  16. Chapman RS, Forsyth A, MacQueen A. Erythema multiforme in association with active ulcerative colitis and Crohn's disease. Dermatologica. 1977;154:32–38
  17. Iannone F, Scioscia C, Musio A, Piscitelli D, Lapadula G. Leucocytoclastic vasculitis as onset symptom of ulcerative colitis. Ann Rheum Dis. 2003;62:785–786
  18. Lambert D, Collet E, Foucher JL, Escallier F, Dalac S. Dermatitis herpetiformis associated with ulcerative colitis. Clin Exp Dermatol. 1991;16:458–459
  19. Smith PK, Davidson GP, Moore L, et al. Epidermolysis bullosa and severe ulcerative colitis in an infant. J Pediatr. 1993;122:600–603
  20. Lotti TM, Comacchi C, Ghersetich I. Cutaneous necrotizing vasculitis. Relation to systemic disease. Adv Exp Med Biol. 1999;455:115–125
  21. Trost LB, McDonnell JK. Important cutaneous manifestations of inflammatory bowel disease. Postgrad Med J. 2005;81:580–585[Review]
  22. Mir-Madjlessi SH, Taylor JS, Farmer RG. Clinical course and evolution of erythema nodosum and pyoderma gangrenosum in chronic ulcerative colitis: a study of 42 patients. Am J Gastroenterol. 1985;80:615–620
  23. Weinstein M, Turner D, Avitzur Y. Erythema nodosum as a presentation of inflammatory bowel disease. CMAJ. 2005;173:145–146
  24. Apgar JT. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: a selective review. Semin Dermatol. 1991;10:138–147
  25. Requena L, Requena C. Erythema nodosum. Dermatol Online J. 2002;8:4;[Review]
  26. Requena L, Yus ES. Panniculitis. Part I. Mostly septal panniculitis. J Am Acad Dermatol. 2001;45:184–186[Review]
  27. Cahill J, Sinclair R. Cutaneous manifestations of systemic disease. Aust Fam Physician. 2005;34:335–340[Review]
  28. Cengiz AB, Kara A, Kanra G, Secmeer G, Ceyhan M. Erythema nodosum in childhood: evaluation of ten patients. Turk J Pediatr. 2006;48:38–42
  29. Mert A, Ozaras R, Tabak F, Pekmezci S, Demirkesen C, Ozturk R. Erythema nodosum: an experience of 10 years. Scand J Infect Dis. 2004;36:424–427
  30. Gonzalez-Gay MA, Garcia-Porrua C, Pujol RM, Salvarani C. Erythema nodosum: a clinical approach. Clin Exp Rheumatol. 2001;19:365–368[Review]
  31. Tromm A, May D, Almus E, et al. Cutaneous manifestations in inflammatory bowel disease. Z Gastroenterol. 2001;39:137–144
  32. Lehman CW. Control of chronic erythema nodosum with naproxen. Cutis. 1980;26:66–67
  33. Horio T, Danno K, Okamoto H, Miyachi Y, Imamura S. Potassium iodide in erythema nodosum and other erythematous dermatoses. J Am Acad Dermatol. 1983;9:77–81
  34. De Coninck P, Baclet JL, Di Bernardo C, Buschges B, Plouvier B. Treatment of erythema nodosum with colchicine. Presse Med. 1984;13:680
  35. Alloway JA, Franks LK. Hydroxychloroquine in the treatment of chronic erythema nodosum. Br J Dermatol. 1995;132:661–662
  36. Levitt MD, Ritchie JK, Lennard-Jones JE, Phillips RK. Pyoderma gangrenosum in inflammatory bowel disease. Br J Surg. 1991;78:676–678
  37. Galbraith SS, Drolet BA, Kugathasan S, Paller AS, Esterly NB. Asymptomatic inflammatory bowel disease presenting with mucocutaneous findings. Pediatrics. 2005;116:e439–e444[Electronic publication 2005 Aug 11]
  38. Schwaegerle SM, Bergfeld WF, Senitzer D, Tidrick RT. Pyoderma gangrenosum: a review. J Am Acad Dermatol. 1988;18:559–568[Review]
  39. Farrell AM, Black MM, Bracka A, Bunker CB. Pyoderma gangrenosum of the penis. Br J Dermatol. 1998;138:337–340[Review]
  40. Mancini GJ, Floyd L, Solla JA. Parastomal pyoderma gangrenosum: a case report and literature review. Am Surg. 2002;68:824–826[Review. Ytting H, Vind I, Bang D, Munkholm P]
  41. Menachem Y, Gotsman I. Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease. Isr Med Assoc J. 2004;6:88–90
  42. Crowson AN, Mihm MC, Magro C. Pyoderma gangrenosum: a review. J Cutan Pathol. 2003;30:97–107[Review]
  43. Callen JP. Pyoderma gangrenosum. Lancet. 1998;351:581–585[Review]
  44. Nerella P, Daniela A, Guido M, Fabbri P. Leukocyte chemotaxis and pyoderma gangrenosum. Int J Dermatol. 1985;24:45–47
  45. Fox LP, Geyer AS, Husain S, Grossman ME. Bullous pyoderma gangrenosum as the presenting sign of fatal acute myelogenous leukemia. Leuk Lymphoma. 2006;47:147–150
  46. Torok L, Kirschner A, Gurzo M, Krenacs L. Bullous pyoderma gangrenosum as a manifestation of leukemia cutis. Eur J Dermatol. 2000;10:463–465
  47. Papageorgiou KI, Mathew RG, Kaniorou-Larai MG, Yiakoumetis A. Pyoderma gangrenosum in ulcerative colitis: considerations for an early diagnosis. BMJ. 2005;331:1323–1324
  48. Reichrath J, Bens G, Bonowitz A, Tilgen W. Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol. 2005;53:273–283[Review]
  49. Futami H, Kodaira M, Furuta T, Hanai H, Kaneko E. Pyoderma gangrenosum complicating ulcerative colitis: successful treatment with methylprednisolone pulse therapy and cyclosporine. J Gastroenterol. 1998;33:408–411
  50. Lopez San Roman A, Bermejo F, Aldanondo I, Carrera E, Boixeda D, Munoz Zato E. Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab. Rev Esp Enferm Dig 2004;96:420-2; 422-4.
  51. Burrall B. Sweet's syndrome (acute febrile neutrophilic dermatosis). Dermatol Online J. 1999;5:8;[Review]
  52. Boye T, Terrier JP, Guennoc B, Fournier B, Carsuzaa F. Neutrophilic dermatosis of the hands. A localized subset of Sweet's syndrome: 3 cases. Ann Dermatol Venereol. 2005;132(11 Pt. 1):883–885
  53. Saliba WR, Goldstein LH, Habib GS, Elias MS. Sweet's syndrome affecting the external auditory canal and tympanic membrane. J Laryngol Otol. 2004;118:48–49
  54. Notani K, Kobayashi S, Kondoh K, Shindoh M, Ferguson MM, Fukuda H. A case of Sweet's syndrome (acute febrile neutrophilic dermatosis) with palatal ulceration. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89:477–479
  55. Sommer S, Wilkinson SM, Merchant WJ, Goulden V. Sweet's syndrome presenting as palmoplantar pustulosis. J Am Acad Dermatol. 2000;42(2 Pt 2):332–334[Review]
  56. Crum NF, Higginbottom PA, Fehl FC, Graham BS. Sweet's syndrome masquerading as facial cellulitis. Cutis. 2003;71:469–472
  57. El Maghraoui A, Abouzahir A, Tabache F, et al. Systemic manifestations of Sweet's syndrome: a case report. Ann Med Interne (Paris). 2000;151:413–416
  58. Mazokopakis E, Kalikaki A, Stathopoulos E, Vrentzos G, Papadakis JA. Acute febrile neutrophilic dermatosis (Sweet's syndrome) with erythema nodosum and anterior scleritis. A case report. Int J Dermatol. 2005;44:1051–1053
  59. Diaz-Peromingo JA, Garcia-Suarez F, Sanchez-Leira J, Saborido-Frojan J. Sweet's syndrome in a patient with acute ulcerative colitis: presentation of a case and review of the literature. Yale J Biol Med. 2001;74:165–168[Review]
  60. Travis S, Innes N, Davies MG, Daneshmend T, Hughes S. Sweet's syndrome: an unusual cutaneous feature of Crohn's disease or ulcerative colitis. The South West Gastroenterology Group. Eur J Gastroenterol Hepatol. 1997;9:715–720
  61. Anglada Pintado JC, Michan Dona A, Silva Abad A, et al. Sweet's syndrome and intestinal inflammatory disease. A case report and review. An Med Interna. 2002;19:419–422[Review]
  62. Darvay A. Sweet's syndrome preceding inflammatory bowel disease. Clin Exp Dermatol. 1996;21:175
  63. von den Driesch P. Sweet's syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol. 1994;31:535–556[quiz 557-60. Review]
  64. Kawakami T, Ohashi S, Kawa Y, et al. Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active Behcet disease: implication in neutrophil apoptosis dysfunction. Arch Dermatol. 2004;140:570–574
  65. Shimizu T, Yoshida I, Eguchi H, Takahashi K, Inada H, Kato H. Sweet syndrome in a child with aplastic anemia receiving recombinant granulocyte colony-stimulating factor. J Pediatr Hematol Oncol. 1996;18:282–284
  66. Von den Driesch P, Simon M, Djawari D, Wassmuth R. Analysis of HLA antigens in Caucasian patients with acute febrile neutrophilic dermatosis (Sweet's syndrome). J Am Acad Dermatol. 1997;37(2 Pt. 1):276–278
  67. Parsapour K, Reep MD, Gohar K, Shah V, Church A, Shwayder TA. Familial Sweet's syndrome in 2 brothers, both seen in the first 2 weeks of life. J Am Acad Dermatol. 2003;49:132–138
  68. Calvo Catala J, Gonzalez Perez JA, Febrer Bosch I, Oliver Mas V, Herrera Ballester A. Sweet's syndrome. Its association with chronic inflammatory bowel disease. An Med Interna. 1990;7:364–366
  69. Cohen PR, Kurzrock R. Sweet's syndrome: a review of current treatment options. Am J Clin Dermatol. 2002;3:117–131[Review]
  70. Paoluzi OA, et al. Diffuse febrile dermatosis in a patient with active ulcerative colitis under treatment with steroids and azathioprine: a case of Sweet's syndrome. Case report and review of literature. Dig Liver Dis. 2004;36:361–366[Review]
  71. Beitman RG, Frost SS, Roth JL. Oral manifestations of gastrointestinal disease. Dig Dis Sci. 1981;26:741–747[Review]
  72. Basu MK, Asquith P. Oral manifestations of inflammatory bowel disease. Clin Gastroenterol. 1980;9:307–321[Review]
  73. Ship JA. Recurrent aphthous stomatitis. An update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81:141–147[Review]
  74. Field EA, Allan RB. Review article: oral ulceration—aetiopathogenesis, clinical diagnosis and management in the gastrointestinal clinic. Aliment Pharmacol Ther. 2003;18:949–962[Review]
  75. Wiik A, Nielsen H, Nielsen OH. Demonstration of circulating immune complexes by the indirect leucocyte phagocytosis test in chronic inflammatory bowel disease. Relation to results of a standard complement consumption assay. Acta Med Scand. 1985;218:73–78
  76. Danis VA, Harries AD, Heatley RV. Antigen-antibody complexes in inflammatory bowel disease. Scand J Gastroenterol. 1984;19:603–606
  77. Sun A, Wu YC, Liang LC, Kwan HW. Circulating immune complexes in recurrent oral ulcers. J Dermatol. 1986;13:170–174
  78. VanHale HM, Rogers RS, Doyle JA, Schroeter AL. Immunofluorescence microscopic studies of recurrent aphthous stomatitis. Arch Dermatol. 1981;117:779–781
  79. Eisen D, Lynch DP. Selecting topical and systemic agents for recurrent aphthous stomatitis. Cutis. 2001;68:201–206[Review]
  80. MacPhail L. Topical and systemic therapy for recurrent aphthous stomatitis. Semin Cutan Med Surg. 1997;16:301–307[Review]
  81. Letsinger JA, McCarty MA, Jorizzo JL. Complex aphthosis: a large case series with evaluation algorithm and therapeutic ladder from topicals to thalidomide. J Am Acad Dermatol. 2005;52(3 Pt 1):500–508[Review]
  82. Storwick GS, Prihoda MB, Fulton RJ, Wood WS. Pyodermatitis-pyostomatitis vegetans: a specific marker for inflammatory bowel disease. J Am Acad Dermatol. 1994;31(2 Pt 2):336–341[Review]
  83. Chan SW, Scully C, Prime SS, Eveson J. Pyostomatitis vegetans: oral manifestation of ulcerative colitis. Oral Surg Oral Med Oral Pathol. 1991;72:689–692
  84. Ruiz-Roca JA, Berini-Aytes L, Gay-Escoda C. Pyostomatitis vegetans. Report of two cases and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99:447–454[Review]
  85. Hegarty AM, Barrett AW, Scully C. Pyostomatitis vegetans. Clin Exp Dermatol. 2004;29:1–7[Review]
  86. Nigen S, Poulin Y, Rochette L, Levesque MH, Gagne E. Pyodermatitis-pyostomatitis vegetans: two cases and a review of the literature. J Cutan Med Surg. 2003;7:250–255[Review]
  87. Soriano ML, Martinez N, Grilli R, Farina MC, Martin L, Requena L. Pyodermatitis-pyostomatitis vegetans: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;87:322–326[Review]
  88. Al-Rimawi HS, Hammad MM, Raweily EA, Hammad HM. Pyostomatitis vegetans in childhood. Eur J Pediatr. 1998;157:402–405[Review]
  89. Hansen LS, Silverman S, Daniels TE. The differential diagnosis of pyostomatitis vegetans and its relation to bowel disease. Oral Surg Oral Med Oral Pathol. 1983;55:363–373
  90. Chaudhry SI, Philpot NS, Odell EW, Challacombe SJ, Shirlaw PJ. Pyostomatitis vegetans associated with asymptomatic ulcerative colitis: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;87:327–330
  91. Calobrisi SD, Mutasim DF, McDonald JS. Pyostomatitis vegetans associated with ulcerative colitis. Temporary clearance with fluocinonide gel and complete remission after colectomy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:452–454
  92. Neville BW, Smith SE, Maize JC, Laden SA, Denton WT. Pyostomatitis vegetans. Am J Dermatopathol. 1985;7:69–77
  93. Markopoulos AK, Antoniades DZ, Gaga E. Pyostomatitis vegetans as an oral manifestation of ulcerative colitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:195–196
  94. VanHale HM, Rogers RS, Zone JJ, Greipp PR. Pyostomatitis vegetans. A reactive mucosal marker for inflammatory disease of the gut. Arch Dermatol. 1985;121:94–98
  95. Werchniak AE, Storm CA, Plunkett RW, Beutner EH, Dinulos JG. Treatment of pyostomatitis vegetans with topical tacrolimus. J Am Acad Dermatol. 2005;52:722–723
  96. Brinkmeier T, Frosch PJ. Pyodermatitis-pyostomatitis vegetans: a clinical course of two decades with response to cyclosporine and low-dose prednisolone. Acta Derm Venereol. 2001;81:134–136
  97. Leibovitch I, Ooi C, Huilgol SC, Reid C, James CL, Selva D. Pyodermatitis-pyostomatitis vegetans of the eyelids case report and review of the literature. Ophthalmology. 2005;112:1809–1813[Review]

PII: S0738-081X(07)00241-6

doi: 10.1016/j.clindermatol.2007.10.018

Clinics in Dermatology
Volume 26, Issue 3 , Pages 265-273 , May 2008

Article Tools

* Image Usage & Resolution